Literature DB >> 31154443

Treatment of Refractory Anti-HMG-CoA Reductase Myopathy: A Role for Rituximab?

Andrew L Mammen1.   

Abstract

Entities:  

Year:  2019        PMID： 31154443     DOI： 10.3899/jrheum.181392

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  2 in total

1.  Progressive neurological symptoms following a fall.

Authors:  Katie Best; Achillefs Spyropoulos
Journal:  Clin Med (Lond)       Date:  2021-03       Impact factor: 2.659

2.  Initial seronegative immune-mediated necrotising myopathy with subsequent anti-HMGCR antibody development and response to rituximab: case report.

Authors:  Rhys Thomas; Su-Ann Yeoh; Rupert Berkeley; Andrew Woods; Mike Stevens; Silvia Marino; Aleksandar Radunovic
Journal:  BMC Rheumatol       Date:  2020-06-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.